EP1147130A4 - ALPHA-conotoxin PEPTIDE - Google Patents

ALPHA-conotoxin PEPTIDE

Info

Publication number
EP1147130A4
EP1147130A4 EP00908382A EP00908382A EP1147130A4 EP 1147130 A4 EP1147130 A4 EP 1147130A4 EP 00908382 A EP00908382 A EP 00908382A EP 00908382 A EP00908382 A EP 00908382A EP 1147130 A4 EP1147130 A4 EP 1147130A4
Authority
EP
European Patent Office
Prior art keywords
alpha
conotoxin peptides
conotoxin
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00908382A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP1147130A1 (en
Inventor
Maren Watkins
Baldomero M Olivera
David R Hillyard
J Michael Mcintosh
Robert M Jones
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cognetix Inc
University of Utah Research Foundation Inc
Original Assignee
Cognetix Inc
University of Utah Research Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cognetix Inc, University of Utah Research Foundation Inc filed Critical Cognetix Inc
Priority to EP07102532A priority Critical patent/EP1852440A1/en
Publication of EP1147130A1 publication Critical patent/EP1147130A1/en
Publication of EP1147130A4 publication Critical patent/EP1147130A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP00908382A 1999-01-29 2000-01-28 ALPHA-conotoxin PEPTIDE Withdrawn EP1147130A4 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP07102532A EP1852440A1 (en) 1999-01-29 2000-01-28 Alpha-conotoxin peptides

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11838199P 1999-01-29 1999-01-29
US118381P 1999-01-29
PCT/US2000/001979 WO2000044776A1 (en) 1999-01-29 2000-01-28 Alpha-conotoxin peptides

Related Child Applications (1)

Application Number Title Priority Date Filing Date
EP07102532A Division EP1852440A1 (en) 1999-01-29 2000-01-28 Alpha-conotoxin peptides

Publications (2)

Publication Number Publication Date
EP1147130A1 EP1147130A1 (en) 2001-10-24
EP1147130A4 true EP1147130A4 (en) 2004-09-29

Family

ID=22378229

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00908382A Withdrawn EP1147130A4 (en) 1999-01-29 2000-01-28 ALPHA-conotoxin PEPTIDE

Country Status (5)

Country Link
EP (1) EP1147130A4 (enExample)
JP (1) JP2002534996A (enExample)
AU (1) AU770076B2 (enExample)
CA (2) CA2361534C (enExample)
WO (1) WO2000044776A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002245934B2 (en) * 2001-03-29 2008-05-01 John Down Alpha conotoxin peptides with analgesic properties
AUPR409401A0 (en) 2001-03-29 2001-04-26 University Of Melbourne, The Analgesic compound
US9284358B2 (en) 2006-07-18 2016-03-15 University Of Utah Research Foundation Conotoxin peptides
CA2657532C (en) 2006-07-18 2019-06-18 University Of Utah Research Foundation Methods for treating pain and screening analgesic compounds
AU2007285045A1 (en) * 2006-08-17 2008-02-21 Eribis Pharmaceuticals Ab Cardioprotective compounds
CN103483439B (zh) 2012-06-15 2015-09-16 海南大学 αO-超家族芋螺毒素肽、其药物组合物及用途
EP2889307B1 (en) * 2012-08-07 2018-05-02 Hainan University Alpha-conotoxin peptide, and medical composition and purpose thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995011256A1 (en) * 1993-10-19 1995-04-27 University Of Utah Research Foundation Conotoxin peptides
WO1998024462A1 (en) * 1996-12-06 1998-06-11 University Of Utah Research Foundation USE OF α-CONOTOXIN MII TO TREAT DISORDERS RESULTING FROM NICOTINE-STIMULATED DOPAMINE RELEASE

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5595972A (en) * 1993-06-29 1997-01-21 University Of Utah Research Foundation Conotoxin peptides
US5432155A (en) * 1993-06-29 1995-07-11 The Salk Institute For Biological Studies Conotoxins I
US5719264A (en) * 1994-10-07 1998-02-17 Univ. Of Utah Research Foundation Conotoxin peptides
US5739276A (en) * 1994-10-07 1998-04-14 University Of Utah Research Foundation Conotoxin peptides
US5670622A (en) * 1996-02-15 1997-09-23 University Of Utah Research Foundation Conotoxin peptide PIIIA
US5672682A (en) * 1996-03-18 1997-09-30 University Of Utah Research Foundation Conotoxin peptide PVIIA
JP2001505878A (ja) * 1996-11-18 2001-05-08 ユニバーシティ・オブ・ユタ・リサーチ・ファウンデーション 心臓血管剤としてのコノトキシンペプチドＩｍＩおよびＭＩＩの使用
US5889147A (en) * 1997-01-17 1999-03-30 University Of Utah Research Foundation Bromo-tryptophan conopeptides
US5866682A (en) * 1997-05-15 1999-02-02 University Of Utah Research Foundation Conopeptides AuIA, AuIB and AuIC
US5969096A (en) * 1998-06-26 1999-10-19 The Salk Institute For Biological Studies Conotoxin peptides

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995011256A1 (en) * 1993-10-19 1995-04-27 University Of Utah Research Foundation Conotoxin peptides
WO1998024462A1 (en) * 1996-12-06 1998-06-11 University Of Utah Research Foundation USE OF α-CONOTOXIN MII TO TREAT DISORDERS RESULTING FROM NICOTINE-STIMULATED DOPAMINE RELEASE

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CARTIER G E ET AL: "A new alpha-Conotoxin Which Targets alpha3beta2 Nicotinic Acetylcholine Receptors", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD, US, vol. 271, no. 13, 23 March 1996 (1996-03-23), pages 7522 - 7528, XP002170539, ISSN: 0021-9258 *
CODIGNOLA AGNESE ET AL: "Alpha-Conotoxin imperialis I inhibits nicotine-evoked hormone release and cell proliferation in human neuroendocrine carcinoma cells", NEUROSCIENCE LETTERS, vol. 206, no. 1, 1996, pages 53 - 56, XP002290023, ISSN: 0304-3940 *
See also references of WO0044776A1 *

Also Published As

Publication number Publication date
AU770076B2 (en) 2004-02-12
EP1147130A1 (en) 2001-10-24
WO2000044776A1 (en) 2000-08-03
CA2743116A1 (en) 2000-08-03
CA2743116C (en) 2016-06-21
AU2973500A (en) 2000-08-18
CA2361534A1 (en) 2000-08-03
JP2002534996A (ja) 2002-10-22
CA2361534C (en) 2011-08-30

Similar Documents

Publication Publication Date Title
PL344341A1 (en) Peptides
GB0128994D0 (en) Peptides
GB9921125D0 (en) Proteins
GB9918156D0 (en) Synthetic peptides
EP1185558A4 (en) PEPTIDES WITH PREPTID FUNCTIONALITY
GB9904695D0 (en) Peptide
EP1147130A4 (en) ALPHA-conotoxin PEPTIDE
GB9812675D0 (en) Peptides
GB9908920D0 (en) Peptide
IL144376A0 (en) Peptides
GB9927681D0 (en) Protein
GB0001825D0 (en) Peptides
GB9918680D0 (en) Polypeptide
GB9807890D0 (en) Peptides
IL150134A0 (en) Apoptin-associating protein
GB9924060D0 (en) VIP54 protein
GB9920000D0 (en) Polypeptides
EP1188828A4 (en) REG-BINDING PROTEIN
GB0007263D0 (en) Peptides
GB9928325D0 (en) Peptides
GB9907911D0 (en) Peptides
GB9917565D0 (en) Peptide
GB9907216D0 (en) Peptide
GB9918606D0 (en) Novel peptides
GB9918599D0 (en) Novel peptides

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010827

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

A4 Supplementary search report drawn up and despatched

Effective date: 20040816

17Q First examination report despatched

Effective date: 20050610

APBN Date of receipt of notice of appeal recorded

Free format text: ORIGINAL CODE: EPIDOSNNOA2E

APBR Date of receipt of statement of grounds of appeal recorded

Free format text: ORIGINAL CODE: EPIDOSNNOA3E

APAF Appeal reference modified

Free format text: ORIGINAL CODE: EPIDOSCREFNE

APBT Appeal procedure closed

Free format text: ORIGINAL CODE: EPIDOSNNOA9E

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20090801